Duearity AB (publ) (DEAR.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.65 Million SEK | 0.0% |
| 2022 | - SEK | -100.0% |
| 2021 | 174.48 Thousand SEK | 27861.7% |
| 2020 | 624.00 SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 244 Thousand SEK | -52.62% |
| 2024 Q1 | 515 Thousand SEK | 27.79% |
| 2023 FY | 1.65 Million SEK | 0.0% |
| 2023 Q2 | 258 Thousand SEK | -56.86% |
| 2023 Q1 | 598 Thousand SEK | 0.0% |
| 2023 Q4 | 403 Thousand SEK | 2.03% |
| 2023 Q3 | 395 Thousand SEK | 53.1% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 FY | - SEK | -100.0% |
| 2022 Q1 | - SEK | 0.0% |
| 2022 Q3 | - SEK | 0.0% |
| 2022 Q2 | - SEK | 0.0% |
| 2021 Q3 | - SEK | 0.0% |
| 2021 FY | 174.48 Thousand SEK | 27861.7% |
| 2021 Q4 | - SEK | 0.0% |
| 2021 Q1 | 175 Thousand SEK | 0.0% |
| 2021 Q2 | - SEK | -100.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2020 FY | 624.00 SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | 73.498% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 99.88% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 99.88% |
| Arcoma AB | 163.01 Million SEK | 98.985% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | 99.189% |
| BICO Group AB (publ) | 2.23 Billion SEK | 99.926% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | 99.71% |
| CellaVision AB (publ) | 677.29 Million SEK | 99.756% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | 80.007% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -69.418% |
| C-Rad AB (publ) | 424.61 Million SEK | 99.61% |
| Dignitana AB (publ) | 86.06 Million SEK | 98.078% |
| Episurf Medical AB (publ) | 10.3 Million SEK | 83.942% |
| Getinge AB (publ) | 31.82 Billion SEK | 99.995% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | 76.633% |
| Integrum AB (publ) | 104.11 Million SEK | 98.411% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -93.518% |
| Mentice AB (publ) | 273.61 Million SEK | 99.395% |
| OssDsign AB (publ) | 112.15 Million SEK | 98.525% |
| Paxman AB (publ) | 210.11 Million SEK | 99.213% |
| Promimic AB (publ) | 37.07 Million SEK | 95.538% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -577.869% |
| SciBase Holding AB (publ) | 23.24 Million SEK | 92.884% |
| ScandiDos AB (publ) | 60.42 Million SEK | 97.263% |
| Sectra AB (publ) | 2.96 Billion SEK | 99.944% |
| Sedana Medical AB (publ) | 153.86 Million SEK | 98.925% |
| Senzime AB (publ) | 35.75 Million SEK | 95.374% |
| SpectraCure AB (publ) | 318 Thousand SEK | -420.126% |
| Stille AB | 294.89 Million SEK | 99.439% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 99.953% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | 99.723% |